Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 18% ± 4% |
Insufficient scRNA-seq data for expression of SESN2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2175.78 | 226 / 226 | 100% | 24.08 | 405 / 406 |
pancreas | 100% | 986.83 | 327 / 328 | 100% | 24.01 | 178 / 178 |
uterus | 100% | 1402.96 | 170 / 170 | 100% | 27.10 | 457 / 459 |
lung | 100% | 1702.42 | 577 / 578 | 99% | 22.27 | 1146 / 1155 |
stomach | 100% | 1342.14 | 359 / 359 | 99% | 25.26 | 283 / 286 |
intestine | 100% | 1374.85 | 966 / 966 | 99% | 22.34 | 521 / 527 |
esophagus | 100% | 1695.14 | 1444 / 1445 | 99% | 22.22 | 181 / 183 |
bladder | 100% | 1286.10 | 21 / 21 | 98% | 24.45 | 496 / 504 |
kidney | 100% | 2258.79 | 89 / 89 | 98% | 27.48 | 886 / 901 |
breast | 100% | 1479.56 | 459 / 459 | 98% | 21.90 | 1099 / 1118 |
skin | 99% | 1619.94 | 1792 / 1809 | 99% | 25.01 | 468 / 472 |
thymus | 99% | 980.22 | 649 / 653 | 99% | 19.64 | 596 / 605 |
ovary | 100% | 4517.53 | 180 / 180 | 97% | 20.80 | 415 / 430 |
brain | 96% | 1002.30 | 2545 / 2642 | 100% | 30.28 | 705 / 705 |
prostate | 100% | 1125.90 | 245 / 245 | 95% | 11.44 | 479 / 502 |
adrenal gland | 100% | 1431.04 | 258 / 258 | 90% | 16.29 | 208 / 230 |
adipose | 100% | 1680.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.35 | 29 / 29 |
spleen | 100% | 1169.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 22.36 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.94 | 1 / 1 |
blood vessel | 99% | 997.18 | 1325 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2331.17 | 918 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 18.20 | 72 / 80 |
heart | 87% | 591.03 | 750 / 861 | 0% | 0 | 0 / 0 |
muscle | 87% | 756.66 | 697 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070328 | Biological process | triglyceride homeostasis |
GO_0042149 | Biological process | cellular response to glucose starvation |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_1990253 | Biological process | cellular response to leucine starvation |
GO_0042593 | Biological process | glucose homeostasis |
GO_0009749 | Biological process | response to glucose |
GO_1903432 | Biological process | regulation of TORC1 signaling |
GO_1901031 | Biological process | regulation of response to reactive oxygen species |
GO_0032868 | Biological process | response to insulin |
GO_0001932 | Biological process | regulation of protein phosphorylation |
GO_0032042 | Biological process | mitochondrial DNA metabolic process |
GO_1904504 | Biological process | positive regulation of lipophagy |
GO_1902010 | Biological process | negative regulation of translation in response to endoplasmic reticulum stress |
GO_0006111 | Biological process | regulation of gluconeogenesis |
GO_0072593 | Biological process | reactive oxygen species metabolic process |
GO_0071233 | Biological process | cellular response to L-leucine |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0016239 | Biological process | positive regulation of macroautophagy |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_1900182 | Biological process | positive regulation of protein localization to nucleus |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0006635 | Biological process | fatty acid beta-oxidation |
GO_0046323 | Biological process | glucose import |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_1904262 | Biological process | negative regulation of TORC1 signaling |
GO_0030330 | Biological process | DNA damage response, signal transduction by p53 class mediator |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0005739 | Cellular component | mitochondrion |
GO_0031588 | Cellular component | nucleotide-activated protein kinase complex |
GO_0031932 | Cellular component | TORC2 complex |
GO_0005829 | Cellular component | cytosol |
GO_1990316 | Cellular component | Atg1/ULK1 kinase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005634 | Cellular component | nucleus |
GO_0004601 | Molecular function | peroxidase activity |
GO_0005092 | Molecular function | GDP-dissociation inhibitor activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0042731 | Molecular function | PH domain binding |
GO_0032542 | Molecular function | sulfiredoxin activity |
GO_0070728 | Molecular function | L-leucine binding |
GO_0016684 | Molecular function | oxidoreductase activity, acting on peroxide as acceptor |
GO_0140311 | Molecular function | protein sequestering activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SESN2 |
Protein name | Sestrin-2 (EC 1.11.1.-) (Hypoxia-induced gene) |
Synonyms | Hi95 SEST2 |
Description | FUNCTION: Functions as an intracellular leucine sensor that negatively regulates the mTORC1 signaling pathway through the GATOR complex . In absence of leucine, binds the GATOR subcomplex GATOR2 and prevents mTORC1 signaling . Binding of leucine to SESN2 disrupts its interaction with GATOR2 thereby activating the TORC1 signaling pathway . This stress-inducible metabolic regulator also plays a role in protection against oxidative and genotoxic stresses. May negatively regulate protein translation in response to endoplasmic reticulum stress, via mTORC1 . May positively regulate the transcription by NFE2L2 of genes involved in the response to oxidative stress by facilitating the SQSTM1-mediated autophagic degradation of KEAP1 . May also mediate TP53 inhibition of TORC1 signaling upon genotoxic stress . Moreover, may prevent the accumulation of reactive oxygen species (ROS) through the alkylhydroperoxide reductase activity born by the N-terminal domain of the protein . Was originally reported to contribute to oxidative stress resistance by reducing PRDX1 . However, this could not be confirmed . . |
Accessions | ENST00000253063.4 P58004 ENST00000645231.2 |